Novartis AG Shares Outstanding 2012-2026 | NVS

Novartis AG shares outstanding for the quarter ending March 31, 2026 were 1.916B, a 3.18% decline year-over-year.

  • Novartis AG 2025 shares outstanding were 1.955B, a 3.93% decline from 2024.
  • Novartis AG 2024 shares outstanding were 2.035B, a 2.72% decline from 2023.
  • Novartis AG 2023 shares outstanding were 2.092B, a 4.78% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Novartis AG Shares Outstanding 2012-2026 | NVS

  • Novartis AG 2025 shares outstanding were 1.955B, a 3.93% decline from 2024.
  • Novartis AG 2024 shares outstanding were 2.035B, a 2.72% decline from 2023.
  • Novartis AG 2023 shares outstanding were 2.092B, a 4.78% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B